Identification of peripheral inflammatory markers between normal control and Alzheimer's disease

Sam Moon Kim, Juhee Song, Seungwoo Kim, Changsu Han, Moon Ho Park, Youngho Koh, Sangmee A. Jo, Young Youl Kim

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Background: Multiple pathogenic factors may contribute to the pathophysiology of Alzheimer's disease (AD). Peripheral blood markers have been used to assess biochemical changes associated with AD and mild cognitive impairment (MCI) and involved in their pathophysiology.Methods: Plasma samples and clinical data were obtained from participants in the Ansan Geriatric Study (AGE study). Plasma concentrations of four candidate biomarkers were measured in the normal control (NC), MCI, and AD group: interleukin-8 (IL-8), IL-10, monocyte chemoattractant protein-1 (MCP-1), and tumor necrosis factor-α (TNF-α).Body mass index (BMI), MMSE (Mini Mental State Examination), CDR(Clinical Dementia Rating) score and homocystein level were recorded with social and demographic information.Results: Total of 59 subjects were randomly selected for this analysis [NC (n = 21), MCI(n = 20) and AD(n = 18)]. In demographic data, educational year was correlated with the diagnosis states (p < 0.0001). No significant differences in cardiovascular disease, BMI and use of NSAIDs were found in MCI or AD group compared with NC group, respectively. The involvement of inflammatory illness or conditions in subjects, WBC count, fibrinogen and homocystein of the three groups, but no significant differences were found in each groups. The plasma IL-8 level was lower in MCI and AD patients compared with the normal control group (respectively, p < 0.0001). The MCI and AD patients had similar MCP-1, IL-10, and TNF-α level.Conclusions: Our study suggests the existence of an independent and negative relationship between plasma IL-8 levels and functional status in MCI and AD patients.

Original languageEnglish
Article number51
JournalBMC Neurology
Volume11
DOIs
Publication statusPublished - 2011 May 12

Fingerprint

Alzheimer Disease
Interleukin-8
Chemokine CCL2
Interleukin-10
Body Mass Index
Tumor Necrosis Factor-alpha
Demography
Control Groups
Non-Steroidal Anti-Inflammatory Agents
Cognitive Dysfunction
Geriatrics
Fibrinogen
Dementia
Cardiovascular Diseases
Biomarkers

Keywords

  • Alzheimer's
  • biomarker
  • IL-8

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Identification of peripheral inflammatory markers between normal control and Alzheimer's disease. / Kim, Sam Moon; Song, Juhee; Kim, Seungwoo; Han, Changsu; Park, Moon Ho; Koh, Youngho; Jo, Sangmee A.; Kim, Young Youl.

In: BMC Neurology, Vol. 11, 51, 12.05.2011.

Research output: Contribution to journalArticle

Kim, Sam Moon ; Song, Juhee ; Kim, Seungwoo ; Han, Changsu ; Park, Moon Ho ; Koh, Youngho ; Jo, Sangmee A. ; Kim, Young Youl. / Identification of peripheral inflammatory markers between normal control and Alzheimer's disease. In: BMC Neurology. 2011 ; Vol. 11.
@article{456c706b2d6046bc882c2b8586018818,
title = "Identification of peripheral inflammatory markers between normal control and Alzheimer's disease",
abstract = "Background: Multiple pathogenic factors may contribute to the pathophysiology of Alzheimer's disease (AD). Peripheral blood markers have been used to assess biochemical changes associated with AD and mild cognitive impairment (MCI) and involved in their pathophysiology.Methods: Plasma samples and clinical data were obtained from participants in the Ansan Geriatric Study (AGE study). Plasma concentrations of four candidate biomarkers were measured in the normal control (NC), MCI, and AD group: interleukin-8 (IL-8), IL-10, monocyte chemoattractant protein-1 (MCP-1), and tumor necrosis factor-α (TNF-α).Body mass index (BMI), MMSE (Mini Mental State Examination), CDR(Clinical Dementia Rating) score and homocystein level were recorded with social and demographic information.Results: Total of 59 subjects were randomly selected for this analysis [NC (n = 21), MCI(n = 20) and AD(n = 18)]. In demographic data, educational year was correlated with the diagnosis states (p < 0.0001). No significant differences in cardiovascular disease, BMI and use of NSAIDs were found in MCI or AD group compared with NC group, respectively. The involvement of inflammatory illness or conditions in subjects, WBC count, fibrinogen and homocystein of the three groups, but no significant differences were found in each groups. The plasma IL-8 level was lower in MCI and AD patients compared with the normal control group (respectively, p < 0.0001). The MCI and AD patients had similar MCP-1, IL-10, and TNF-α level.Conclusions: Our study suggests the existence of an independent and negative relationship between plasma IL-8 levels and functional status in MCI and AD patients.",
keywords = "Alzheimer's, biomarker, IL-8",
author = "Kim, {Sam Moon} and Juhee Song and Seungwoo Kim and Changsu Han and Park, {Moon Ho} and Youngho Koh and Jo, {Sangmee A.} and Kim, {Young Youl}",
year = "2011",
month = "5",
day = "12",
doi = "10.1186/1471-2377-11-51",
language = "English",
volume = "11",
journal = "BMC Neurology",
issn = "1471-2377",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Identification of peripheral inflammatory markers between normal control and Alzheimer's disease

AU - Kim, Sam Moon

AU - Song, Juhee

AU - Kim, Seungwoo

AU - Han, Changsu

AU - Park, Moon Ho

AU - Koh, Youngho

AU - Jo, Sangmee A.

AU - Kim, Young Youl

PY - 2011/5/12

Y1 - 2011/5/12

N2 - Background: Multiple pathogenic factors may contribute to the pathophysiology of Alzheimer's disease (AD). Peripheral blood markers have been used to assess biochemical changes associated with AD and mild cognitive impairment (MCI) and involved in their pathophysiology.Methods: Plasma samples and clinical data were obtained from participants in the Ansan Geriatric Study (AGE study). Plasma concentrations of four candidate biomarkers were measured in the normal control (NC), MCI, and AD group: interleukin-8 (IL-8), IL-10, monocyte chemoattractant protein-1 (MCP-1), and tumor necrosis factor-α (TNF-α).Body mass index (BMI), MMSE (Mini Mental State Examination), CDR(Clinical Dementia Rating) score and homocystein level were recorded with social and demographic information.Results: Total of 59 subjects were randomly selected for this analysis [NC (n = 21), MCI(n = 20) and AD(n = 18)]. In demographic data, educational year was correlated with the diagnosis states (p < 0.0001). No significant differences in cardiovascular disease, BMI and use of NSAIDs were found in MCI or AD group compared with NC group, respectively. The involvement of inflammatory illness or conditions in subjects, WBC count, fibrinogen and homocystein of the three groups, but no significant differences were found in each groups. The plasma IL-8 level was lower in MCI and AD patients compared with the normal control group (respectively, p < 0.0001). The MCI and AD patients had similar MCP-1, IL-10, and TNF-α level.Conclusions: Our study suggests the existence of an independent and negative relationship between plasma IL-8 levels and functional status in MCI and AD patients.

AB - Background: Multiple pathogenic factors may contribute to the pathophysiology of Alzheimer's disease (AD). Peripheral blood markers have been used to assess biochemical changes associated with AD and mild cognitive impairment (MCI) and involved in their pathophysiology.Methods: Plasma samples and clinical data were obtained from participants in the Ansan Geriatric Study (AGE study). Plasma concentrations of four candidate biomarkers were measured in the normal control (NC), MCI, and AD group: interleukin-8 (IL-8), IL-10, monocyte chemoattractant protein-1 (MCP-1), and tumor necrosis factor-α (TNF-α).Body mass index (BMI), MMSE (Mini Mental State Examination), CDR(Clinical Dementia Rating) score and homocystein level were recorded with social and demographic information.Results: Total of 59 subjects were randomly selected for this analysis [NC (n = 21), MCI(n = 20) and AD(n = 18)]. In demographic data, educational year was correlated with the diagnosis states (p < 0.0001). No significant differences in cardiovascular disease, BMI and use of NSAIDs were found in MCI or AD group compared with NC group, respectively. The involvement of inflammatory illness or conditions in subjects, WBC count, fibrinogen and homocystein of the three groups, but no significant differences were found in each groups. The plasma IL-8 level was lower in MCI and AD patients compared with the normal control group (respectively, p < 0.0001). The MCI and AD patients had similar MCP-1, IL-10, and TNF-α level.Conclusions: Our study suggests the existence of an independent and negative relationship between plasma IL-8 levels and functional status in MCI and AD patients.

KW - Alzheimer's

KW - biomarker

KW - IL-8

UR - http://www.scopus.com/inward/record.url?scp=79955781066&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955781066&partnerID=8YFLogxK

U2 - 10.1186/1471-2377-11-51

DO - 10.1186/1471-2377-11-51

M3 - Article

VL - 11

JO - BMC Neurology

JF - BMC Neurology

SN - 1471-2377

M1 - 51

ER -